Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan
· Delayed Price · Currency is TWD 220.00
-1.00 (-0.45%)
Jun 27, 2025, 2:38 PM CST
Lotus Pharmaceutical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 5,465 | 5,066 | 4,106 | 3,021 | 1,403 | 1,027 | Upgrade
|
Depreciation & Amortization | 1,308 | 1,273 | 1,200 | 926.96 | 748.76 | 697.88 | Upgrade
|
Other Amortization | 10.01 | 10.13 | 10.23 | 9.91 | 10.62 | 11.74 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.18 | 0.7 | 24.75 | -2.52 | 3.2 | 4.68 | Upgrade
|
Asset Writedown & Restructuring Costs | 159.99 | 159.99 | 179.37 | 136.67 | 234.82 | 127.68 | Upgrade
|
Loss (Gain) From Sale of Investments | -579.05 | -604.16 | -715.05 | -286.81 | - | - | Upgrade
|
Loss (Gain) on Equity Investments | - | - | - | - | - | -3.78 | Upgrade
|
Stock-Based Compensation | 346.26 | 348.65 | 106.49 | 39.41 | 57.66 | 31.22 | Upgrade
|
Provision & Write-off of Bad Debts | -0.53 | -2.96 | -4.04 | -3.33 | 34.24 | -0.66 | Upgrade
|
Other Operating Activities | 610.26 | 615.83 | 144.35 | 788.08 | 460.19 | 352.13 | Upgrade
|
Change in Accounts Receivable | -635.71 | -850.77 | -1,665 | -1,373 | -633.42 | -496.3 | Upgrade
|
Change in Inventory | -160.84 | -181.33 | -623.18 | -313.29 | -1,125 | -1,098 | Upgrade
|
Change in Accounts Payable | 226.45 | 346.45 | -659.57 | 648.39 | -980.98 | 996.45 | Upgrade
|
Change in Unearned Revenue | 10.65 | 32.93 | -69.33 | 20 | -9.74 | 72.51 | Upgrade
|
Change in Other Net Operating Assets | 358.61 | -59.23 | -420.87 | 108.67 | -83.63 | 225.84 | Upgrade
|
Operating Cash Flow | 7,119 | 6,155 | 1,614 | 3,719 | 119.66 | 1,949 | Upgrade
|
Operating Cash Flow Growth | 114.14% | 281.29% | -56.60% | 3008.27% | -93.86% | 364.03% | Upgrade
|
Capital Expenditures | -472.62 | -353.84 | -410.57 | -577.16 | -572.73 | -413.79 | Upgrade
|
Sale of Property, Plant & Equipment | 0.61 | 0.61 | 1.25 | 9.38 | 0.11 | 0.05 | Upgrade
|
Cash Acquisitions | -1,242 | -1,242 | - | - | - | 77.38 | Upgrade
|
Sale (Purchase) of Intangibles | -2,449 | -1,112 | -2,864 | -2,492 | -1,043 | -1,584 | Upgrade
|
Investment in Securities | - | - | - | -1,583 | - | 12.13 | Upgrade
|
Other Investing Activities | 18.69 | 15.82 | 24.48 | -13.38 | 38.8 | 783.15 | Upgrade
|
Investing Cash Flow | -4,144 | -2,691 | -3,249 | -4,656 | -1,577 | -1,125 | Upgrade
|
Short-Term Debt Issued | - | 2,378 | 1,216 | 1,435 | 1,291 | - | Upgrade
|
Long-Term Debt Issued | - | 2,951 | 20,476 | 6,250 | 5,063 | 5,550 | Upgrade
|
Total Debt Issued | 4,950 | 5,328 | 21,692 | 7,685 | 6,354 | 5,550 | Upgrade
|
Short-Term Debt Repaid | - | -1,260 | -861.82 | -2,100 | -870.8 | -50 | Upgrade
|
Long-Term Debt Repaid | - | -2,123 | -18,522 | -3,259 | -5,642 | -3,616 | Upgrade
|
Total Debt Repaid | -4,264 | -3,382 | -19,384 | -5,359 | -6,513 | -3,666 | Upgrade
|
Net Debt Issued (Repaid) | 685.6 | 1,946 | 2,308 | 2,326 | -159.41 | 1,883 | Upgrade
|
Issuance of Common Stock | 0.26 | 0.26 | 0.6 | - | 1,414 | - | Upgrade
|
Repurchase of Common Stock | - | - | - | - | -57.35 | - | Upgrade
|
Common Dividends Paid | -1,232 | -1,232 | -906.23 | -506.06 | -92.01 | - | Upgrade
|
Other Financing Activities | -0.11 | -0.31 | - | -558.27 | 558.31 | -2,429 | Upgrade
|
Financing Cash Flow | -545.93 | 714.09 | 1,403 | 1,262 | 1,663 | -545.31 | Upgrade
|
Foreign Exchange Rate Adjustments | 53.89 | 81 | 19.91 | 52.89 | -89.52 | -66.4 | Upgrade
|
Net Cash Flow | 2,484 | 4,259 | -212.5 | 377.89 | 116.49 | 212.14 | Upgrade
|
Free Cash Flow | 6,647 | 5,801 | 1,204 | 3,142 | -453.07 | 1,535 | Upgrade
|
Free Cash Flow Growth | 126.86% | 381.96% | -61.70% | - | - | 1673.70% | Upgrade
|
Free Cash Flow Margin | 34.77% | 31.21% | 7.10% | 21.47% | -3.58% | 14.31% | Upgrade
|
Free Cash Flow Per Share | 25.21 | 22.02 | 4.59 | 12.01 | -1.76 | 6.30 | Upgrade
|
Cash Interest Paid | 481.96 | 495.06 | 446.25 | 290.7 | 227.93 | 393.36 | Upgrade
|
Cash Income Tax Paid | 943.16 | 915.24 | 1,036 | 444.89 | 259.57 | 89.65 | Upgrade
|
Levered Free Cash Flow | 2,672 | 3,200 | -4,296 | 1,917 | -1,801 | -137.68 | Upgrade
|
Unlevered Free Cash Flow | 3,017 | 3,551 | -3,963 | 2,139 | -1,634 | 52.61 | Upgrade
|
Change in Net Working Capital | -124.41 | 478.04 | 5,181 | -1,576 | 2,416 | -221.59 | Upgrade
|
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.